Publications

May 2020

Abstract

ASCO Annual Meeting

Overall survival in Non-small cell lung cancer patients with comorbidities treated with frontline chemotherapy or immunotherapy: a real-world data collaboration

Rivera, DR, Lasiter, L, Christian, JB, Enewold, L, Espirito, JL, Hansen, E, Henk, HJ, Kushi, L, Lane, D, Natanzon, Y, Benito, RP, Rasmussen, E, Robert, NJ, Stewart, M, Sweetnam, C, Tymejczyk, O, Valice, E, Wagner, J, Zander, A, Allen, J

May 2020

Abstract

ASCO Annual Meeting

Flatiron-authored

Concurrent or layered treatment with radium-223 and enzalutamide or abiraterone/prednisone: real-world clinical outcomes in patients with metastatic castration-resistant prostate cancer

Shore, ND, Higano, CS, George, DJ, Sternberg, CN, Saad, F, Tombal, B, Miller, K, Kalinovsky, J, Jiao, X, Tangirala, K, Sartor, AO

May 2020

Manuscript

Prostate Cancer and Prostatic Diseases

April 2020

Manuscript

PLoS One

Flatiron-authored

April 2020

Manuscript

ESMO Open

April 2020

Manuscript

Clinical Lung Cancer

Flatiron-authored

Primary tumor location and survival in colorectal cancer: A retrospective cohort study

Aggarwal, H, Sheffield, KM, Li, L, Lenis, D, Sorg, RA, Barzi, A, Miksad, RA

April 2020

Manuscript

World Journal of Gastrointestinal Oncology

Flatiron-authored

April 2020

Manuscript

Lung Cancer

April 2020

Manuscript

Cancer Discovery

Flatiron-authored

March 2020

Manuscript

medRxiv

Flatiron-authored

Quality measurement in cancer care: A review and endorsement of high-impact measures and concepts

D'Amico, TA, Bandini, L, Balch, A, Benson III, AI, Edge, SB, Fitzgerald, L, Green, RJ, Koh, W, Kolodziej, MA, Kumar, S, Meropol, NJ, Mohler, JL, Pfister, D, Walters, RS, Carlson, RW

March 2020

Manuscript

JNCCN

Flatiron-authored

Author’s response to ‘‘A Letter in Support of Real-World RECIST’’

Griffith, SD, Tucker, MG, Bowser, B, Calkins, G, Chang, C, Guardino, E, Khozin, S, Kraut, J, You, P, Schrag, D, Miksad, RA

February 2020

Manuscript

Advances in Therapy

Flatiron-authored

Real-world dosing patterns and outcomes of patients with metastatic pancreatic cancer treated with a liposomal irinotecan regimen in the United States

Barzi, A, Miksad, RA, Surinach, A, Corvino, FA, Wang, S, Torres, AZ, Mamlouk, K, Pulgar, S, Valderrama, A, Bekaii-Saab, T, Ahn, D

January 2020

Manuscript

Pancreas

Flatiron-authored

Assessing real-world biomarker testing rates in metastatic colon cancer

Nakhoda, S, Deng, M, Iyer, P, Handorf, E, Jain, R, Meropol, NJ, Dotan, E

January 2020

Abstract

ASCO GI Symposium

Flatiron-authored

January 2020

Abstract

ASCO GI Symposium

Flatiron-authored

January 2020

Abstract

ASCO GI Symposium

January 2020

Abstract

ASCO GI Symposium

Real-world treatment patterns and survival in patients (pts) with hepatocellular carcinoma in the United States

Morse, M, Meyer, A-M, Lawrance, M, Pereira, M, Mhatre, SK, Gaillard, V, Dayyani, F

January 2020

Abstract

ASCO GI Symposium

January 2020

Abstract

ASCO GI Symposium

January 2020

Abstract

ASCO GI Symposium

January 2020

Abstract

ASCO GI Symposium

Association of real-world agreement between HER2 expression and ERBB2 amplification with trastuzumab therapy benefit in advanced gastric/esophageal (adv GE) cancer patients (pts)

Stein, S, Snider, J, McCusker, M, Miksad, RA, Alexander, BM, Castellanos, EH, Backenroth, D, Schrock, AB, Madison, R, Carson, KR, Ali, SM

January 2020

Abstract

ASCO GI Symposium

Flatiron-authored

January 2020

Abstract

ASCO GI Symposium

Comparative-effectiveness of pembrolizumab vs nivolumab for patients with metastatic melanoma

Moser, JC, Wei, G, Colonna, SV, Grossman, KF, Patel, SB, Hyngstrom, JR

January 2020

Manuscript

Acta Oncologia

Prognostic significance of cancer patient reported outcomes in cancer

Kerrigan, KC, Patel, SB, Halland, B, Ose, D, Chalmers, AW, Haydell, T, Meropol, NJ, Akerley, WL

January 2020

Manuscript

Journal of Oncology Practice

Flatiron-authored

Treatment patterns and outcomes in patients with metastatic castration-resistant prostate cancer in a real-world clinical practice setting in the United States

George, DJ, Sartor, AO, Miller, K, Saad, F, Tombal, B, Kalinovsky, J, Jiao, X, Tangirala, K, Sternberg, CN, Higano, CS

January 2020

Manuscript

Clinical Genitourinary Cancer

First-line immune checkpoint inhibitor use in cisplatin-eligible patients with advanced urothelial carcinoma: a secular trend analysis

Parikh, RB, Feld, EK, Galsky, MD, Adamson, BJS, Cohen, AB, Baxi, SS, Boursi, SB, Christodouleas, JP, Vaughn, DJ, Meropol, NJ, Mamtani, R

December 2019

Manuscript

Future Oncology

Flatiron-authored

December 2019

Abstract

San Antonio Breast Cancer Symposium

Initial real-world treatment patterns and outcomes of abemaciclib for the treatment of HR+HER2-metastatic breast cancer

Carter, GC, Sheffield, KM, Gossai, A, Huang, Y, Zhu, YE, Bowman, L, Smyth, EN, Mathur, R, Cohen, AB, Baxi, SS, Rybowski, S, Chong, AL, Seidman, AD

December 2019

Abstract

San Antonio Breast Cancer Symposium

Flatiron-authored

December 2019

Abstract

San Antonio Breast Cancer Symposium

December 2019

Abstract

San Antonio Breast Cancer Symposium

Visualization of the relationship between survival and sequential treatments in metastatic breast cancer

Rocque, GB, Gilbert, A, Williams, CP, Nakhmani, A, Kandhare, PG, Azuero, A, Bhatia, S, Kenzik, KM, Burkard, ME

December 2019

Abstract

San Antonio Breast Cancer Symposium

December 2019

Abstract

San Antonio Breast Cancer Symposium

December 2019

Abstract

San Antonio Breast Cancer Symposium

December 2019

Abstract

San Antonio Breast Cancer Symposium

Overall survival for first-line palbociclib plus letrozole alone for HR+/HER2- metastatic breast cancer patients in US real-world clinical practice

DeMichele, A, Cristofanilli, M, Brufsky, A, Liu, X, Mardekian, J, McRoy, L, Layman, RM, Rugo, HS, Finn, RS

December 2019

Abstract

San Antonio Breast Cancer Symposium

December 2019

Abstract

San Antonio Breast Cancer Symposium

December 2019

Abstract

American Society of Hematology Annual Meeting

Flatiron-authored

December 2019

Abstract

American Society of Hematology Annual Meeting

Flatiron-authored

December 2019

Abstract

American Society of Hematology Annual Meeting

December 2019

Abstract

American Society of Hematology Annual Meeting

December 2019

Abstract

American Society of Hematology Annual Meeting

Flatiron-authored

December 2019

Abstract

American Society of Hematology Annual Meeting

December 2019

Abstract

American Society of Hematology Annual Meeting

December 2019

Abstract

American Society of Hematology Annual Meeting

Flatiron-authored

December 2019

Abstract

American Society of Hematology Annual Meeting

Challenges and opportunities to updating prescribing information for longstanding oncology drugs

Balogh, EP, Bindman, AB, Eckhardt, SG, Halabi, S, Harvey, RD, Jaiyesimi, I, Miksad, RA, Moses, HL, Nass, SJ, Schilsky, RL, Sun, S, Torrente, JM, Warren, KE

December 2019

Manuscript

The Oncologist

Flatiron-authored

November 2019

Abstract

EU ISPOR

A landmark response analysis to determine cost-effectiveness of third-line nivolumab for small cell lung cancer

Smare, C, Dave, K, Juarez-Garcia, A, Schoenherr, N, Abraham, P, Penrod, JR, Camidge, DR, Yuan, Y

November 2019

Abstract

EU ISPOR

A partitioned survival model to determine cost-effectiveness of third-line nivolumab monotherapy for small cell lung cancer

Smare, C, Dave, K, Juarez-Garcia, A, Schoenherr, N, Abraham, P, Penrod, JR, Camidge, DR, Yuan, Y

November 2019

Abstract

EU ISPOR